Deirdre P. Connelly - 12 Sep 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown as Attorney-in-Fact for Deirdre Connelly
Issuer symbol
SRPT
Transactions as of
12 Sep 2024
Net transactions value
$0
Form type
4
Filing time
16 Sep 2024, 20:05:03 UTC
Previous filing
01 Jul 2024
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +2,842 $0.000000 2,842 12 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Award $0 +6,442 $0.000000 6,442 12 Sep 2024 Common Stock 6,442 $125.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning September 12, 2025.
F2 The option vests in three equal annual installments beginning September 12, 2025.